nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—BCHE—diaphragm—amyotrophic lateral sclerosis	0.137	0.275	CbGeAlD
Doxacurium chloride—CHRNA1—tongue—amyotrophic lateral sclerosis	0.101	0.204	CbGeAlD
Doxacurium chloride—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.024	0.0483	CbGeAlD
Doxacurium chloride—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.0214	0.043	CbGeAlD
Doxacurium chloride—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.0194	0.039	CbGeAlD
Doxacurium chloride—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.0192	0.0382	CbGpPWpGaD
Doxacurium chloride—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.0187	0.0375	CbGeAlD
Doxacurium chloride—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.0182	0.0367	CbGeAlD
Doxacurium chloride—CHRNA1—brain—amyotrophic lateral sclerosis	0.0179	0.0359	CbGeAlD
Doxacurium chloride—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.017	0.0341	CbGeAlD
Doxacurium chloride—CHRNA2—brain—amyotrophic lateral sclerosis	0.0148	0.0298	CbGeAlD
Doxacurium chloride—BCHE—brainstem—amyotrophic lateral sclerosis	0.0147	0.0295	CbGeAlD
Doxacurium chloride—CHRNB1—brain—amyotrophic lateral sclerosis	0.0138	0.0277	CbGeAlD
Doxacurium chloride—CHRM2—nervous system—amyotrophic lateral sclerosis	0.0116	0.0232	CbGeAlD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0115	0.0229	CbGpPWpGaD
Doxacurium chloride—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.0111	0.0224	CbGeAlD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0106	0.0211	CbGpPWpGaD
Doxacurium chloride—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.0102	0.0206	CbGeAlD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00977	0.0194	CbGpPWpGaD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00937	0.0186	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00929	0.0185	CbGpPWpGaD
Doxacurium chloride—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00912	0.0183	CbGeAlD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00902	0.0179	CbGpPWpGaD
Doxacurium chloride—CHRM2—brain—amyotrophic lateral sclerosis	0.00884	0.0178	CbGeAlD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00864	0.0172	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00857	0.017	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00804	0.016	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00797	0.0159	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00797	0.0158	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0077	0.0153	CbGpPWpGaD
Doxacurium chloride—BCHE—nervous system—amyotrophic lateral sclerosis	0.00769	0.0155	CbGeAlD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00757	0.0151	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00756	0.015	CbGpPWpGaD
Doxacurium chloride—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00743	0.0148	CbGpPWpGaD
Doxacurium chloride—BCHE—central nervous system—amyotrophic lateral sclerosis	0.0074	0.0149	CbGeAlD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00735	0.0146	CbGpPWpGaD
Doxacurium chloride—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00723	0.0145	CbGeAlD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00704	0.014	CbGpPWpGaD
Doxacurium chloride—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00704	0.014	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00698	0.0139	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00678	0.0135	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00662	0.0132	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00655	0.013	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00655	0.013	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00655	0.013	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00644	0.0128	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00622	0.0124	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00611	0.0122	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00599	0.0119	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0059	0.0117	CbGpPWpGaD
Doxacurium chloride—BCHE—brain—amyotrophic lateral sclerosis	0.00587	0.0118	CbGeAlD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00584	0.0116	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00569	0.0113	CbGpPWpGaD
Doxacurium chloride—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00563	0.0112	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00563	0.0112	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00557	0.0111	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00557	0.0111	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0054	0.0107	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00535	0.0106	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00529	0.0105	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00529	0.0105	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0052	0.0103	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00518	0.0103	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00502	0.00998	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00502	0.00998	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00502	0.00998	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00496	0.00987	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00494	0.00982	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00477	0.00948	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00472	0.00938	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00459	0.00913	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00447	0.0089	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00436	0.00867	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00427	0.00849	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00427	0.00849	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00421	0.00837	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00405	0.00806	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00405	0.00806	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00393	0.00781	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00385	0.00766	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0038	0.00756	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00361	0.00719	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00355	0.00707	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00347	0.00691	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00343	0.00683	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.0032	0.00637	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00314	0.00625	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00305	0.00606	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00295	0.00587	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00292	0.00581	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00292	0.00581	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00279	0.00554	CbGpPWpGaD
Doxacurium chloride—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00278	0.00553	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00272	0.00542	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00271	0.00539	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00271	0.00539	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00271	0.00539	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00263	0.00523	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00263	0.00523	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0026	0.00518	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00259	0.00515	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00243	0.00484	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00241	0.00479	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00241	0.00479	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00224	0.00445	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00224	0.00445	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00199	0.00397	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00199	0.00397	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00195	0.00389	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00194	0.00387	CbGpPWpGaD
Doxacurium chloride—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00194	0.00386	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00167	0.00332	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00164	0.00327	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00155	0.00309	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.0014	0.00279	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00138	0.00275	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00136	0.0027	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00136	0.0027	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00126	0.00252	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00124	0.00247	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00118	0.00235	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00118	0.00234	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00115	0.00229	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00108	0.00216	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000981	0.00195	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000868	0.00173	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000853	0.0017	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000743	0.00148	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000701	0.00139	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000686	0.00136	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000678	0.00135	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000669	0.00133	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000625	0.00124	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000607	0.00121	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000595	0.00118	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000563	0.00112	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000516	0.00103	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000514	0.00102	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000473	0.000941	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000445	0.000885	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000422	0.000839	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000408	0.000813	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000367	0.00073	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000363	0.000721	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000359	0.000713	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000352	0.0007	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000303	0.000602	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.0003	0.000596	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000292	0.00058	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000278	0.000553	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000265	0.000527	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000246	0.00049	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000231	0.00046	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000229	0.000455	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00022	0.000438	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000188	0.000375	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000177	0.000352	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000157	0.000312	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000157	0.000311	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000146	0.00029	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00012	0.00024	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.27e-05	0.000184	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.76e-05	0.000174	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.87e-05	0.000156	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.94e-05	0.000118	CbGpPWpGaD
